Fralin Biomedical Research Institute: AI-backed Saliva Test Shows Promise for Flagging Chemotherapy Risk, Early Results Indicate
April 23, 2025
April 23, 2025
ROANOKE, Virginia, April 23 (TNSres) -- The Fralin Biomedical Research Institute at Virginia Tech issued the following news:
* * *
AI-backed saliva test shows promise for flagging chemotherapy risk, early results indicate
By John Pastor
Early results from a new study suggest that a simple saliva test with powerful artificial intelligence (AI) algorithms could help doctors identify cancer patients at high risk for severe side effects from a wid . . .
* * *
AI-backed saliva test shows promise for flagging chemotherapy risk, early results indicate
By John Pastor
Early results from a new study suggest that a simple saliva test with powerful artificial intelligence (AI) algorithms could help doctors identify cancer patients at high risk for severe side effects from a wid . . .